As Emory researchers develop strategies to diagnose
individuals in the very early stages of
Alzheimer’s disease, the need to develop effective
treatments that target symptoms of the disease
and slow its progression remains critical. Emory
researchers are using findings obtained from basic
science research to target possible strategies to halt
or slow the progression of Alzheimer’s disease. A
variety of clinical trials are currently being conducted
at Emory. Research examining high-dose
vitamin supplements as well as studies testing novel surgical techniques to slow brain
degeneration are among a number of active clinical studies. Experts at Emory are also
conducting exciting studies exploring the ways in which sleep is disturbed by neurodegenerative
diseases such as Alzheimer’s and how specific sleep disorders may cause or
contribute to the development of cognitive decline as individuals age. The rapid pace of
progress in Alzheimer’s research will continue to generate abundant opportunities for
patients to partner with Emory clinicians and investigators in cutting-edge research to
aggressively pursue a cure for this debilitating disease.